Turnaround

Investors in Merck are grappling with uncertainty following the U.S. market entry of generic competitors for Mavenclad, a key multiple...

Aya Gold & Silver stands at a pivotal moment in its corporate evolution. Having deployed significant capital to expand its...

ABO Wind AG is navigating the most severe crisis in its nearly three-decade history. The outcome of a critical bondholder...

The German pharmaceutical packaging specialist Gerresheimer finds itself navigating its most severe corporate turmoil in recent memory. A combination of...

The immediate future for Technovative investors hinges on a single regulatory classification. Currently trading within the highly restricted "Expert Market,"...

Biotechnology firm Tevogen Bio Holdings is embarking on a significant corporate transformation, centered on a comprehensive overhaul of its executive...

All eyes will be on Fiserv CEO Mike Lyons tomorrow as he takes the stage at the Wolfe Fintech Forum....

A major legal overhang for the telehealth company Hims & Hers has been decisively removed, sending its shares skyrocketing. The...

The medical technology firm Strata Skin Sciences is moving to formally terminate its status as a publicly traded company. This...

Navitas Semiconductor Corporation is undertaking a fundamental strategic overhaul, shifting its entire focus toward artificial intelligence infrastructure. This move away...